Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: effects of docetaxel on immune enhancement (Q37193049)

From Wikidata

Jump to navigation Jump to search

scientific article published on June 2008

Language	Label	Description	Also known as
English	Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: effects of docetaxel on immune enhancement	scientific article published on June 2008

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: effects of docetaxel on immune enhancement (English)

1 reference

Europe PubMed Central

18 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Jeffrey Schlom

1 reference

Europe PubMed Central

18 August 2017

author name string

Charlie T Garnett

1

1 reference

Europe PubMed Central

18 August 2017

James W Hodge

3

1 reference

Europe PubMed Central

18 August 2017

language of work or name

0 references

publication date

1 June 2008

1 reference

Europe PubMed Central

18 August 2017

Clinical Cancer Research

1 reference

Europe PubMed Central

18 August 2017

14

1 reference

Europe PubMed Central

18 August 2017

11

1 reference

Europe PubMed Central

18 August 2017

3536-3544

1 reference

Europe PubMed Central

18 August 2017

Cancer vaccines: moving beyond current paradigms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

6 September 2017

A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

6 September 2017

Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

6 September 2017

Docetaxel: an alternative taxane in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

6 September 2017

Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

6 September 2017

Chemotherapy: friend or foe to cancer vaccines?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

6 September 2017

Enhancement of tumor radioresponse by docetaxel: Involvement of immune system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

6 September 2017

The immunological effects of taxanes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

6 September 2017

External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

14 September 2017

Phase II trial of docetaxel (Taxotere) in patients with metastatic melanoma previously untreated with cytotoxic chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

14 September 2017

Identification of an interferon-gamma-inducible carcinoembryonic antigen (CEA) CD8(+) T-cell epitope, which mediates tumor killing in CEA transgenic mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

28 September 2017

Docetaxel alone or orally combined with 5-fluorouracil and its derivatives: effects on mouse mammary tumor cell line MM2 in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

28 September 2017

Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

28 September 2017

Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

28 September 2017

Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

26 June 2018

Taxol-mediated changes in fibrosarcoma-induced immune cell function: modulation of antitumor activities.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

26 June 2018

The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

3 September 2018

Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

3 September 2018

Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

3 September 2018

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

3 September 2018

Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897): a trial of the Eastern Cooperative Oncology Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

3 September 2018

A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

3 September 2018

Preclinical antitumor activity of two novel taxanes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

3 September 2018

Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2682419

3 September 2018

Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/18519787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized phase II study of docetaxel alone or in combination with PANVAC-V (vaccinia) and PANVAC-F (fowlpox) in patients with metastatic breast cancer (NCI 05-C-0229)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18519787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer vaccines: toward the next revolution in cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18519787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative studies of a retrovirus versus a poxvirus vector in whole tumor-cell vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/18519787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A triad of costimulatory molecules synergize to amplify T-cell activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18519787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic anti-tumoral effect of paclitaxel (Taxol)+AS101 in a murine model of B16 melanoma: association with ras-dependent signal-transduction pathways

1 reference

https://pubmed.ncbi.nlm.nih.gov/18519787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel-induced mobilization of hematopoietic stem cells in a murine model: kinetics, dose titration, and toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18519787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant

1 reference

https://pubmed.ncbi.nlm.nih.gov/18519787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18519787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergy of vaccine strategies to amplify antigen-specific immune responses and antitumor effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/18519787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor alpha and interleukin-1 in macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/18519787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Taxol provides a second signal for murine macrophage tumoricidal activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18519787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mice transgenic for the human carcinoembryonic antigen gene maintain its spatiotemporal expression pattern

1 reference

https://pubmed.ncbi.nlm.nih.gov/18519787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between the structure of taxol and other taxanes on induction of tumor necrosis factor-alpha gene expression and cytotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18519787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18519787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-07-4025

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37193049&oldid=1693738168"